These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11390510)

  • 21. The vascular biology of macrophage migration inhibitory factor (MIF). Expression and effects in inflammation, atherogenesis and angiogenesis.
    Asare Y; Schmitt M; Bernhagen J
    Thromb Haemost; 2013 Mar; 109(3):391-8. PubMed ID: 23329140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin E is a MIF Inhibitor.
    Hegde B; Vadnal P; Sanghavi J; Korde V; Kulkarni-Almeida AA; Dagia NM
    Biochem Biophys Res Commun; 2012 Feb; 418(2):384-9. PubMed ID: 22281490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STATs in cancer inflammation and immunity: a leading role for STAT3.
    Yu H; Pardoll D; Jove R
    Nat Rev Cancer; 2009 Nov; 9(11):798-809. PubMed ID: 19851315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Golgi-associated protein p115 mediates the secretion of macrophage migration inhibitory factor.
    Merk M; Baugh J; Zierow S; Leng L; Pal U; Lee SJ; Ebert AD; Mizue Y; Trent JO; Mitchell R; Nickel W; Kavathas PB; Bernhagen J; Bucala R
    J Immunol; 2009 Jun; 182(11):6896-906. PubMed ID: 19454686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrophage migration inhibitory factor (MIF) tautomerase inhibitors as potential novel anti-inflammatory agents: current developments.
    Garai J; Lóránd T
    Curr Med Chem; 2009; 16(9):1091-114. PubMed ID: 19275614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical role of cysteine residue 81 of macrophage migration inhibitory factor (MIF) in MIF-induced inhibition of p53 activity.
    Jung H; Seong HA; Ha H
    J Biol Chem; 2008 Jul; 283(29):20383-96. PubMed ID: 18502749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage migration inhibitory factor induces MMP-9 expression in macrophages via the MEK-ERK MAP kinase pathway.
    Yu X; Lin SG; Huang XR; Bacher M; Leng L; Bucala R; Lan HY
    J Interferon Cytokine Res; 2007 Feb; 27(2):103-9. PubMed ID: 17316137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The apoptosis-associated protein BNIPL interacts with two cell proliferation-related proteins, MIF and GFER.
    Shen L; Hu J; Lu H; Wu M; Qin W; Wan D; Li YY; Gu J
    FEBS Lett; 2003 Apr; 540(1-3):86-90. PubMed ID: 12681488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity.
    Bloom BR; Bennett B
    Science; 1966 Jul; 153(3731):80-2. PubMed ID: 5938421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophage migration inhibitory factor blockade reprograms macrophages and disrupts prosurvival signaling in acute myeloid leukemia.
    Spertini C; Bénéchet AP; Birch F; Bellotti A; Román-Trufero M; Arber C; Auner HW; Mitchell RA; Spertini O; Smirnova T
    Cell Death Discov; 2024 Mar; 10(1):157. PubMed ID: 38548753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Five-hub genes identify potential mechanisms for the progression of asthma to lung cancer.
    Yang W; Li Z; Wang W; Wu J; Ye X
    Medicine (Baltimore); 2023 Feb; 102(6):e32861. PubMed ID: 36820598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-Cell RNA Sequencing Reveals Heterogeneity in the Tumor Microenvironment between Young-Onset and Old-Onset Colorectal Cancer.
    Li GM; Xiao GZ; Qin PF; Wan XY; Fu YJ; Zheng YH; Luo MY; Ren DL; Liu SP; Chen HX; Lin HC
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune subgroup analysis for non-small cell lung cancer may be a good choice for evaluating therapeutic efficacy and prognosis.
    Tian Y; Wang J; Wen Q; Su G; Sun Y
    Aging (Albany NY); 2021 May; 13(9):12691-12709. PubMed ID: 33973529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MIF-Dependent Control of Tumor Immunity.
    Noe JT; Mitchell RA
    Front Immunol; 2020; 11():609948. PubMed ID: 33324425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic role of macrophage migration inhibitory factor expression in patients with squamous cell carcinoma of the lung.
    Koh HM; Kim DC; Kim YM; Song DH
    Thorac Cancer; 2019 Dec; 10(12):2209-2217. PubMed ID: 31602798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crotoxin promotes macrophage reprogramming towards an antiangiogenic phenotype.
    de Araújo Pimenta L; de Almeida MES; Bretones ML; Cirillo MC; Curi R; Sampaio SC
    Sci Rep; 2019 Mar; 9(1):4281. PubMed ID: 30862840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between macrophage migration inhibitory factor and autophagy in Helicobacter pylori-associated gastric carcinogenesis.
    Yoon K; Kim N; Park Y; Kim BK; Park JH; Shin CM; Lee DH; Surh YJ
    PLoS One; 2019; 14(2):e0211736. PubMed ID: 30742638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral squamous carcinoma cells promote macrophage polarization in an MIF-dependent manner.
    Barbosa de Souza Rizzo M; Brasilino de Carvalho M; Kim EJ; Rendon BE; Noe JT; Darlene Wise A; Mitchell RA
    QJM; 2018 Nov; 111(11):769-778. PubMed ID: 30016493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanomedicine Strategies to Target Tumor-Associated Macrophages.
    Binnemars-Postma K; Storm G; Prakash J
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28471401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PPAR Agonists for the Prevention and Treatment of Lung Cancer.
    Lakshmi SP; Reddy AT; Banno A; Reddy RC
    PPAR Res; 2017; 2017():8252796. PubMed ID: 28316613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.